Top compounds associated with response to CHFR


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Bosutinib GDSC1000 pan-cancer AAC 0.015 0.7
mRNA Bexarotene GDSC1000 pan-cancer AAC 0.016 0.7
mRNA BRD-K35604418 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.015 0.7
mRNA cimetidine CTRPv2 pan-cancer AAC 0.03 0.7
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.016 0.7
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.016 0.7
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC 0.032 0.7
mRNA paclitaxel FIMM pan-cancer AAC 0.061 0.7
Download CSV